-+ 0.00%
-+ 0.00%
-+ 0.00%

MeiraGTx announces FDA Breakthrough Therapy designation for AAV2-hAQP1 for grade 2 and 3 radiation-induced xerostomia

Reuters·03/26/2026 12:05:00

Please log in to view news